Traduction de «laboratory of experimental medicine » (Néerlandais → Français) :

Laboratory of Experimental Medicine and Endocrinology Campus Gasthuisberg Katholieke Universiteit Leuven Herestraat 49 3000 Leuven Toegekend bedrag: € 140 000, verdeeld over 2 jaar
Laboratory of Experimental Medicine and Endocrinology Campus Gasthuisberg Katholieke Universiteit Leuven Herestraat 49 3000 Leuven Montant octroyé: € 140 000, répartis sur 2 ans

Naam: Viggo Van Tendeloo Opleiding: master in de biochemie gevolgd door een doctoraatsthesis in de Wetenschappen Beroep: onderzoeker die zich specialiseert in celtherapie Instelling: Vaccine & Infectious Disease Institute - Laboratory of Experimental Hematology (Universiteit Antwerpen) Type onderzoek: fundamenteel en klinisch Terrein van onderzoek: immunotherapie
Nom : Viggo Van Tendeloo Formation : maîtrise en Biochimie suivie d’une thèse de doctorat en Sciences Profession : chercheur spécialisé en thérapie cellulaire Etablissement : Vaccine & Infectious Disease Institute - Laboratory of Experimental Hematology (Université d’Anvers) Type de recherche : fondamentale & clinique Domaine de recherche : l’immunothérapie

Universiteit Antwerpen Vaccine & Infectious Disease Institute Laboratory of Experimental Hematology Wilrijkstraat 10 Edegem
Universiteit Antwerpen Vaccine & Infectious Disease Institute Laboratory of Experimental Hematology Wilrijkstraat 10

Experimental Medicine – LEGENDO Campus Gasthuisberg O&N1 Katholieke Universiteit Leuven Herestraat 49 bus 902 3000 Leuven Toegekend bedrag: € 320 000, verdeeld over 4 jaar
Experimental Medicine – LEGENDO Campus Gasthuisberg O&N1 Katholieke Universiteit Leuven Herestraat 49 bus 902 3000 Leuven Montant octroyé: € 320 000, répartis sur 4 ans

narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September
narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September

The latter has been designated as having expertise as an “Official Medicines Control Laboratory”, recognised by the FAMHP and the European Directorate for the Quality of Medicines (EDQM), for the monitoring of immunological products for veterinary use prior to marketing authorisation for the Belgian market.
The latter has been designated as having expertise as an “Official Medicines Control Laboratory”, recognised by the FAMHP and the European Directorate for the Quality of Medicines (EDQM), for the monitoring of immunological products for veterinary use prior to marketing authorisation for the Belgian market.

The external services of Unit II inspect manufacturers of medicines (in Belgium and non-EU countries), the wholesalers, the recognised laboratories, the companies recognised on the basis of the royal decree on raw materials used by the pharmacist, the manufacturers of “Active Pharmaceutical Ingredient” (API), blood establishments and cell and tissue banks.
The external services of Unit II inspect manufacturers of medicines (in Belgium and non-EU countries), the wholesalers, the recognised laboratories, the companies recognised on the basis of the royal decree on raw materials used by the pharmacist, the manufacturers of “Active Pharmaceutical Ingredient” (API), blood establishments and cell and tissue banks.